Figure9.

Comparison of the number of osteoblasts (A) and osteocytes (B) between the HA/ZrO₂/PRP-treated defects and the HA/ZrO₂ and PRP-treated defects.

¥ Significant difference with the PRP-treated defects at the second week (all Ps=0.001).

Ϩ Significant difference with the counterparts at the sixth week (P=0.009 and P=0.017, respectively).

£ Significant difference with all the other groups (all Ps=0.0001).

Д Significant difference with the counterparts at the sixth and eighth weeks (P=0.001 and P=0.007, respectively).